The neuroprotectant may ease oxidative stress in MS Patients.
Because oxidative stress is high in subjects with multiple sclerosis (MS), Polish researchers are investigating the neuroprotectant melatonin as an ingredient for MS relief.
Researchers assigned 16 multiple sclerosis patients to 10 mg of melatonin daily for 30 days and compared contents of their red blood cells to those of 13 age-matched controls. The researchers specifically looked for changes in concentrations of malondialdehyde (an oxidative stress marker) and the antioxidant enzymes superoxide dismutase, catalase, and glutathione peroxide.
After one month of supplementation, two of three antioxidant enzymes statistically increased in MS patients, and malondialdehyde also significantly decreased. The results of this preliminary study warrant future research on melatonin and subjects with progressive MS.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.